Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent form of chronic liver disease, with a global prevalence of 25% worldwide, but a consensus treatment is still lacking. Previous studies have shown that Jian-Pi Huo-Xue granules (JPHX) can reduce hepatic steatosis in u...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuanlong, Chen, Gaofeng, Chen, Si, Wang, Yanjie, Hu, Yiyang, Zhao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164345/
https://www.ncbi.nlm.nih.gov/pubmed/35655225
http://dx.doi.org/10.1186/s13063-022-06393-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164345/
https://www.ncbi.nlm.nih.gov/pubmed/35655225
http://dx.doi.org/10.1186/s13063-022-06393-8

Ejemplares similares